From Evolution to Revolution: How the Rise of Specialty Pharmacy Drove a New PBM Model

As an Executive of Growth & Strategy for AscellaHealth, Mike leads Market Access, Business Development & Corporate Strategy for Specialty / Infusion Pharmacy Segments, he provides business strategies of all portfolio management. Within his roles, he ensures the success of the widest variety of strategic projects across departmental segments, applies strategic business development, contract negotiations, network development, marketing & outreach strategies, and other business development initiatives that cultivate opportunities that affect client segments. Identify pressing market factors and drive strategic business strategy for all facets related to the specialty market.

With more than 21+ years of specialty pharmacy, pharmaceutical and biotech industry experience, including roles in national and regional managed markets, specialty supply channels, sales management and specialty brand management, Mr. Baldzicki offers strategic insight into specialty pharmacy trends, distribution, contracting, reimbursement, and the application of health outcomes and economic evidence to prove value proposition. He is a recognized leader in the specialty pharmaceutical market for developing and implementing key payer and specialty pharmacy agreements that result in documented savings for specialty market segments.

Mr. Baldzicki held roles in senior executive management within the specialty pharmacy supply group, pharmaceutical and biotech industry of managed markets, group purchasing organizations, specialty wholesale, and integrated delivery networks. He assumed roles within the pharmaceutical organization such as Bristol-Myers Squibb, Enzon BioTech, Novo Nordisk, Baxter BioScience, as well as roles within the distribution channel of AmerisourceBergen specialty groups, BioMatrix Specialty & Infusion Rx, Diplomat/BioRx Specialty Pharmacy, CareCentrix Medical Infusion, Asembia GPO, Axelacare Infusion, to other manufacturer & specialty pharmacy home infusion companies. He brings expertise in business development, managed markets, specialty pharmacy, hospital health systems, reimbursement, and brand management for biologics, including specialty infusion therapies for bloods products, hematology, oncology, and other rare orphan drugs.